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INTRODUCTION AND OVERVIEW 
Impaired awareness of illness has been known for hundreds of years. In 
1604 in his play, "The Honest Whore", Thomas Dekker has a character say: 
"That proves you mad because you know it not". Among neurologists, 
unawareness of illness is well known since it also occurs in some individuals 
with stroke, brain tumors, Alzheimer's disease and Huntington's disease. The 
term “anosognosia” was first used by a French neurologist in 1914 (Prigatono  
and Schacter, 1991). 
The Oxford English Dictionary defines Insight as "an inner sight, a  
discernment, a wisdom (or) glimpse of you beneath the surface”. To put it 
simply, it means the capacity to understand the hidden truth. Insight, as a 
concept of a symptom, got introduced during the later part of the 19th century 
by Dagonet (1881). 
In 1934, Aubrey Lewis provided a temporary definition of Insight: “a 
correct attitude to morbid change in oneself”, but warned that the words 
‘correct’, ‘attitude’, ‘morbid’ and ‘change’ each called for discussion. He also 
said, “All questions of the judgment of reality, such as…. the consideration of 
insight, go to the root of the psychopathology of different conditions” 
The usage of the word by Gestalt psychologists for an “aha” experience 
(Harre and Lamb, 1983; Conrad, 1958) and the psychoanalytic classification 
into ‘emotional’ and ‘intellectual’ is avoided here (Zilborg, 1952; Sandler et al., 
1973). 
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Our study is restricted to the usage of the word for recognizing one’s 
own mental disorder, medication effects, social consequences, awareness and 
attribution of signs and symptoms.  
Even in our clinical setting, some patients with schizophrenia do accept 
that they have something wrong in them even though they decline to accept 
that they have a psychiatric illness.  
Probably their sociocultural and religious matrix colors their expression. 
At times even if the patient denies mental disorder, he accepts distress 
and accepts drugs without protesting. So, here is the question whether insight is 
an all (or) none phenomenon. 
Insight is a multidimensional and not an unitary phenomenon (Amador,   
et al., 1993). 
The component dimensions of insight are continuous rather than 
dichotomous phenomena. In other words one can have partial insight. 
Insight into mental disorder may be modality specific i.e. the level of 
insight can vary across the many manifestations of illness. For example a 
patient may be aware of his flat affect, but he may be unaware of his asociality. 
Insight comprises of the processes of awareness and attribution. 
Awareness is the recognition of signs or symptoms of illness, while attribution 
refers to explanations about the cause or source of the signs or symptoms. 
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A patient may be aware of "alogia" but may not attribute the decrease in 
verbal abilities to a mental disorder. 
A patient may deny that he is currently mentally ill, but may accept that 
he was mentally ill in the past. 
Again, a patient may deny having mental illness and still accept 
treatment and vice versa. 
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REVIEW OF LITERATURE 
The relationship between schizophrenia and poor insight was identified 
even when the disorder was first named by Bleuler (Bertschinger, 1916; 
Mayer- Gross, 1920 as cited by Wciorka, 1988). Poor insight as a symptom is a 
consistent accompaniment of schizophrenia (Carpenter et al., 1973). In fact 
lack of insight was the most frequent symptom occurring in the world health 
organization (WHO), International pilot study of schizophrenia (IPSS) in 1973. 
Assessing insight is involved with a lot of controversies. Insight is 
assessed as part of standard mental state examination, but no guidelines exist as 
how to quantify or qualify it. (Markova & Berrios, 1992). Among all the 
parameters of the mental status examination, it has the poorest construct 
validity, with little consensus among different authors on its clinical 
implications. Lack of insight is considered to be characteristic of psychotic 
disorders.  
Interest in the concept of insight in psychosis has been revived recently 
(David, 1990; Amador et al., 1991; Ghaemi & Pope, 1994; Cuesta & Peralta, 
1994; Amador & David, 1996; David et al., 1995). The clinical importance of 
insight is now being studied. Certain themes have been examined such as: the 
relationship between insight and treatment compliance (McEvoy et al., 1989a; 
Buchanan, 1992); the specificity of poor insight for the diagnosis of 
schizophrenia (Wing et al., 1974; Amador et al., 1994); the link between 
insight and cognitive impairment (young et al., 1993; Cuesta & Peralta 1994; 
Lysaker et al., 1996); cerebral ventricular enlargement (Takai et al., 1992) and 
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finally the value of insight as a predictor of better outcome (McGlashan et al., 
1981; McEvoy et al., 1989b). 
The Assessment of insight 
In general, the approaches used in the assessment of insight can be 
divided into a) categorical i.e., insight is viewed as an all or none phenomenon 
(described as present or absent), or categorized into more groups (described as 
present, partially present or absent) and b) continuous i.e., insight is 
conceptualized as a continuous process and assessed in terms of scores from 
structured schedules based on an unitary concept (McEvoy et al., 1989a) or on 
multidimensional models (Amador et al., 1991; David,1990). 
Problems beset the categorical approach. A common one is that anchor 
points such as full, partial or absent are rarely defined as in Eskey (1958), 
Heinrich et al., (1985), Van Putten et al., (1976), Cuesta & Peralta (1994) and 
Takai et al., (1992) where more or less structured methods of mental state 
examination were used but the scalar criteria were not specified. Furthermore, 
the categorization approach is based on narrow definitions of insight, generally 
couched in terms of recognition or awareness of mental illness, with some 
adding awareness of need for treatment. Narrow definitions entail a view of 
insight as a “discrete entity” or “symptom” that is not semantically coterminous 
with the idea of “awareness”, with which it is often combined.  
 The dimensional approach, on the other hand, has endeavoured to 
broaden and operationalize the assessment of insight. McEvoy et al., (1989a), 
devised the Insight and Treatment Attitude Questionnaire (ITAQ) to assess 
patients’ awareness of their illness and perceived need for treatment and 
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hospitalization. This standardized instrument yields insight scores but is based 
on a fairly narrow definition of insight and focuses on the degree of correlation 
between attitudes of patients and staff rather than on patients’ subjective views. 
More recently, some have viewed insight as “multidimensional” (Amador       
et al., 1991; David, 1990; Greenfield et al., 1989), i.e., as consisting of related 
dimensions susceptible to assessment and quantification by standard schedules. 
Thus, David (1990) proposes three dimensions: awareness of mental illness, 
awareness of the need for treatment and the ability to relabel psychotic 
experiences as abnormal. Amador et al., (1991), on the other hand, suggest a 
broader multidimensional construct of insight as comprising of: a) awareness of 
the signs, symptoms and consequences of illness, b) general attribution about 
illness and specific attribution about symptoms and their consequences, c) self-
concept formation and d) self-defensiveness. In their empirical work, however, 
Amador et al., (1993) base their assessment of insight on different dimensions, 
namely, awareness of illness (general and particular symptoms), attribution 
regarding illness and symptoms, achieved effects of medication and awareness 
of social consequences of having a mental disorder. They also include 
retrospective views.    
Retrospective Insight 
Expecting insight from a psychiatrically ill person is asking for a great 
deal but not the impossible. Modern authors readily accept the notion that there 
are degrees of insight (Gelder et al., 1983) of which the retrospective variety is 
as valid as any other, and that its development is an integral part of the 
recovery process (Landis, 1964). When a patient accepts mental illness of the 
past he is said to have retrospective insight. Bleuler, (1924) and Jaspers, (1913) 
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warned us to be cautious in interpreting such retrospective insight and not to 
believe totally the claims of patients that they have become aware of the past 
unreal experiences. Wing et al., (1964) asked a group of 113 male 
schizophrenia patients just before discharge whether they would classify 
themselves as having been mentally ill. 20% answered yes; 52% used words 
like ‘strain’ and ‘nerves’ ; 23% said that their own delusions and hallucinations 
indicated that they had been mentally ill. Cutting et al., (1985), asked 20 
remitted patients whether they thought that they had been mentally ill. 
Seventeen said yes and he concluded that a surprising proportion of patients do 
possess insight contrary to the expectation of many psychiatrists. 
Is Insight a good thing ? 
Insight, when it is absent causes poor drug compliance and prognosis. 
When excessive it may be associated with depression and hence a poor 
outcome. This leads us to the question how much insight is necessary?.         
McGlashan et al., (1981), concluded that absence of negative attitude is more 
necessary than a positive attitude. Roback & Abramowitz (1979), showed that 
patients with insight were better adjusted behaviorally during the hospital stay, 
yet they were more psychologically distressed. Insight was considered by 
David (1990) as a painful struggle against a psychotic disturbance and that the 
lack of insight might serve a protective function. That lack of insight goes 
along with elevated and elated mood is supported by several authors (Van 
Putten et al., 1976; Heinrich et al.,1985; Bartko et al., 1988). This grandiose 
conviction that one’s mental health is intact seems to serve a protective 
function in schizophrenia patients, albeit temporarily. It is possible to have too 
much insight subjecting oneself to a sick role and continuous torturing self-
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examination. Both too much and too little could be construed as abnormal 
illness behaviour (Pilowsky, 1978). A compromise might be sufficient insight 
to accept treatment, but not so much that it encourages brooding on the reality 
of how severely ill one is. 
This formulation has parallels in the demonstrably more favorable 
prognosis achieved by cancer patients who adopt a fighting spirit.            
(Greer, 1983). 
Pseudoinsight 
Jaspers (1913), cautions about pseudoinsight when the patient may 
accept the problem as that of ‘ego boundaries’ or ‘chemical imbalance’. He 
simply regurgitates the explanations he has overheard. This acceptance may be 
similar to his acceptance of its occurrence due to voodoo spell. Insight need not 
imply knowledge of causality either, a view at odds with psychoanalytic 
formulations (Reid and Finesinger, 1952; Blum, 1979). It simply requires the 
acceptance of personal illness affecting the mental apparatus (the ability to 
think, perceive, act, remember etc) whose etiology may be and often is 
unknown. Nevertheless, pseudoinsight of the kind described above may have a 
hermeneutic value to the patient in establishing order in the midst of chaos and 
may initiate a process leading to what could be called true insight. 
Relationship of insight to compliance & outcome:  
Insight is frequently assumed to predict treatment compliance. There is 
enough evidence that a strong association is present between poor insight and 
poor drug compliance (Bartko et al., 1988; Van Putten et al., 1976). Also 
 9
presence of insight can predict successful implementation of treatment in 
schizophrenia (Lin et al., 1979; Heinrich et al., 1985). Lin et al., (1979), studied 
100 schizophrenia patients and found that over half of the patients with insight 
did not take their medicine regularly and 17% of those without insight were 
treatment compliant. Heinrich et al., (1985), found that the presence of insight 
i.e., the ability to recognize a relapse in the early stages of decomposition, was 
associated with greater successful resolution of the relapse. McEvoy (1981), 
asked 45 schizophrenia patients whether they felt they were ill and required 
treatment. Only 13% agreed that they were ill, with 27% accepting a need for 
medication. Van Putten et al., (1976), compared 30 drug compliers and 29 drug 
refusers and showed that compliers had better insight. Bartko et al., (1988), did 
a similar study in 32 noncompliant patients and showed them to have poorer 
insight when compared to drug compliers. 
In conclusion one can say that insight clearly aids compliance. It was 
noted that patients can have no insight into illness and still accept and derive 
benefit from treatment. It was then recommended that drug compliance and 
awareness of illness be regarded as separate though overlapping constructs, 
which contribute to insight. 
         Impaired awareness of illness is one important reason why individuals 
with schizophrenia and bipolar disorder do not take medication. Without 
medication, the person's symptoms become worse. This often makes them more 
vulnerable to being victimized and committing suicide. It also often leads to 
rehospitalization, homelessness, being incarcerated in jail or prison and violent 
acts against others because of the untreated symptoms (Lacro et al., 2002). 
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Insight and violence  
Compared with the nonviolent patients, violent patients were more 
symptomatic, had poorer functioning and had a more prominent lack of insight 
(Buckley et al., 2004). 
Insight and Social skill 
Lysaker et al., (1998), suggest that poor insight into mental illness may 
interfere with one’s social relationships due to discrepancy between how 
persons with mental illness see themselves and how others view them. He also 
found that persons with impaired insight had significant lower scores on 
interpersonal relatedness (e.g. frequency of social contacts) and basic 
interpersonal skills. (e.g. empathy, rapport). In a similar vein, others have 
found relationships between decreased awareness of mental disorder and 
increased social isolation, decreased social activities, lower social functioning 
and smaller social networks (Amador et al., 1994; Dickerson et al., 1997; Smith 
et al., 1999; White et al., 2000). In a study done by J L Francis et al., (2001), he 
concluded that greater insight was associated with better overall social skill, 
less observed strangeness and a greater self disclosure of one’s mental illness. 
Insight-depression-suicidality 
“…the correlation between truth and happiness is not invariably 
positive…” (Sackeim, 1998) 
The majority of empirical studies indicate that increased insight serves 
to improve the functioning of patients with schizophrenia. Suicide is one area 
of research in which increased awareness is correlated with heightened 
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mortality and morbidity. In particular, patients’ awareness of current asociality, 
delusions, anhedonia and blunted affect may significantly increase the risk of 
suicidality (Amador et al., 1996). Patients who achieve a nondelusional 
awareness of their illness and its consequences manifest a substantially 
increased risk of completing suicide (Drake et al., 1986). Schwartz and 
Peterson (1999), found that as patients’ awareness of their need for psychiatric 
treatment increased, overall severity of current suicidality also increased. A 
later replication study similarly found that insight into need for treatment was 
significantly correlated with ratings of suicidal intent. Additionally, awareness 
of social consequences of the disorder predicted heightened suicidality. 
(Schwartz, 2000a). Good premorbid adjustment combined with schizophrenic 
patients’ awareness of the psychotic syndrome and its impending disabilities 
may lead to depressive symptomatology and eventual suicidality. It was 
hypothesized that insight into illness and its life long consequences may 
predispose schizophrenia patients to a demoralization syndrome that spirals 
towards severe depression and suicidal ideation, a common syndrome that has 
important implications for clinical practice (Schwartz, 2000b). Schwartz (2001) 
showed that depression significantly increased as patients self-awareness 
increased. Combining these findings he proposed the linear insight-
demoralization-depression-suicidality syndrome in schizophrenia patients. 
These findings point to a need to assess, monitor and intervene in 
schizophrenia patients with insight for depressive symptomatology. 
Insight and delusion 
Delusions are false judgments held with extraordinary convictions. 
Conviction is an essential part of delusions according to Jaspers, Kraeplin & 
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DSM-IV’s operational definition. This position has been challenged by several 
authors who do not accept that delusions are unitary concepts (Junginger & 
Frame, 1985). In addition and of most relevance here, they contest the notion of 
absolute conviction (Kendler et al., 1983; Garety1985; Brett-Jones et al., 1987). 
It is assumed that as conviction diminishes, insight increases. One conclusion is 
that, like the allied concept of insight, delusions are most usefully regarded as 
multidimensional. The degree of conviction in the deluded may vary 
considerably. Sacks et al., (1974), called this the “double awareness phase” in 
the recovery from delusions, although similar states also occur during their 
onset (Maher & Ross, 1984). These states may arise from rapid oscillation 
between belief and disbelief or because an individual becomes amenable to 
testing still firmly held beliefs held against reality. Amador et al., (1993), also 
agree to the multidimensional concept of delusion. He says that he has seen 
many patients with fixed false beliefs who still have partial awareness of the 
delusion (awareness that the idea is not shared by others, is implausible, 
violates laws of nature etc.) 
Models of insight 
Several correlational patterns have begun to emerge within the study of 
insight in schizophrenia. These have solidified into three main schools of 
thought regarding etiology: the Psychological Defense Model; the Cognitive 
Deficit Model and the Neuropsychological Deficit Model (Rickelman, 2004). 
The Psychological Defense Model: This was practically the only 
existing school of thought about insight prior to 1990. The prevailing 
assumption was that failure to recognize or admit to a psychiatric illness was a 
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conscious (or sub-conscious) refusal rather than an inability. It was further 
assumed that knowledge of the illness did exist at some cognitive level. 
      Historically, self-awareness deficits in schizophrenia have been most often 
understood as stemming from psychological defenses or adaptive coping 
strategies. Mayer-Gross (1920), classified defensive strategies of schizophrenia 
patients into 4 categories: denial of future, creation of new life after illness, 
denial of psychotic experience and melting of the psychotic experience into a 
new set of life experiences. In their review of literature of post psychotic 
depression, McGlashan and Carpenter (1976) identified its relation to denial in 
schizophrenia. They stated that postpsychotic depression arises from a 
lessening of defensive denial, which results in the patients becoming aware of 
the tragic circumstances of their illness. McGlashan (1975) suggested that there 
exists a continuum of recovery styles. On one end lies ‘sealing over’ i.e, 
patients who prefer not to think or talk about their psychotic experience. On the 
other end lies ‘integration’ i.e, patients who are willing to discuss about the 
psychotic experience and learn more about themselves. These were interpreted 
and reflected as coping strategies applicable to other stressful events besides 
schizophrenia. The frequent finding that poor insight is positively correlated 
with elated mood and grandiosity has also been interpreted as evidence that 
poor insight serves a defensive function (Van Putten et al., 1976). 
The Cognitive Deficit Model: In contrast, the Cognitive Deficit Model 
acknowledges a slightly more organic etiology to impaired insight. Drawing on 
research that has linked decreasing insight to increasingly poor scores on the 
Wisconsin Card Sorting Test (WCST) and other measures of cognitive function 
(Keshavan et al., 2004; Lele, 1998; Young et al., 1993), the Cognitive Deficit 
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Model suggests that poor insight is a result of progressively degenerating 
cognitive functioning over the course of the illness. Given the high frequency 
of poor insight seen in first-episode schizophrenia patients (Keshavan              
et al., 2004), progressive degeneration does not seem to be a likely causal 
factor for poor insight. However, this does not discount cognitive functions as a 
correlation factor. In fact, the link between poor WCST scores, a known 
measure of frontal lobe function and poor insight in schizophrenia patients may 
be evidence for a more neurological basis of impaired insight. . Donohoe et al., 
(2005) concluded that while impaired insight does appear to be associated with 
executive deficits, this association may not be specific but may instead relate to 
cognitive deficits more generally. Craig Goodman et al., (2005) found that 
there is an association between poor insight and cognitive impairment in 
patients with schizophrenia, but concluded that the relationship may not 
specifically involve frontal lobe dysfunction. 
The Neuropsychological Deficit Model: The Neuropsychological Deficit 
Model developed out of an identified similarity between the symptoms of poor 
insight and a neurological condition called anosognosia. Generally developing 
secondary to a specific lesion (such as a focal traumatic brain injury) or diffuse 
brain damage (such as a stroke), anosognosia is an acknowledged neurological 
deficit. Patients afflicted with anosognosia share striking similarities with 
psychiatric patients who have impaired insight (Amador and Paul-Odouard, 
2000; Lele et al., 1998). Both have a severe lack of awareness of their deficits, 
which persist despite all evidence to the contrary, have a strong desire to prove 
their own assertions and as such, invent confabulations to explain away 
pathological symptoms. Furthermore, both sets of patients often demonstrate 
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(through functional or imaging tests) frontal lobe deficits. Lele and Joglekar 
(1998), have carried the analogy further, pointing out that both anosognosia 
and poor insight in schizophrenia can be either generalized (relating to all 
aspects of the disease) or domain-specific (patient is aware of certain 
symptoms or functional deficits, but not others). Amador et al., (1994) have 
likewise identified what they call "spotty insight" among schizophrenia patients 
The specific brain areas that appear to be most involved are the frontal 
lobe and part of the parietal lobe (Flashman et al., 2001; Amador & David        
et al., 2004). 
A number of researchers (Weiler et al., 2000; Rusch and Corrigan 2002; 
Smith et al., 2004) have concluded that insight is likely a function of several 
cognitive, social and biological factors, many of which may work in tandem to 
produce various types of insight impairments. 
Several authors have correlated deficits in insight with both 
neuroanatomic abnormalities in frontal lobe (Flashman et al., 2001) as well to 
poor performance in task related to frontal lobe activation (Keshavan                
et al., 2004; Lele, 1998; Young et al., 1993). Smith et al., (2004) have proposed 
one possible mechanism that integrates current models of awareness, involving 
frontal-cortical-striatal circuitry abnormalities. 
Comparing insight across the psychoses  
Many studies of individuals with schizophrenia report that 
approximately half of them have moderate or severe impairment in their 
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awareness of illness. Studies suggest that approximately 40 percent of 
individuals with bipolar disorder have impaired awareness of illness.  
Studies done by Amador et al., (1994), showed that deficits in insight 
have been found to be more common and more severe in patients with 
schizophrenia, than in patients with schizoaffective and major depression with 
or without psychosis, but not more severe than they are in patients with bipolar 
disorder. 
 Studies done by Pini et al., (2001), replicated the above finding. They 
evaluated 29 inpatients with schizophrenia, 24 with schizoaffective disorder, 
and 183 with mood disorders with psychotic features (153 with bipolar disorder 
and 30 with unipolar depression). They found that insight deficits did not differ 
between schizophrenia & bipolar mood disorder. In addition, they found that 
patients with schizophrenia had poorer insight than patients with 
schizoaffective disorder and patients with psychotic unipolar depression. 
Correlations were found in the direction of association between poorer insight 
and poorer psychosocial functioning. They went on to suggest that future 
studies should examine whether patients with bipolar disorder with very poor 
insight show a pattern of neurocognitive deficit similar to that found in 
schizophrenia and whether level of insight is related to state versus trait in this 
group.      
Studies done by Fennig et al., (1996), showed that lack of insight is 
more prevalent in schizophrenia and improves over time. They also mentioned 
that components of prior treatment leading to better insight should be explored. 
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Chen at al., (2001), also found that patients with schizophrenia have 
poorer insight compared to other psychotic disorders including mania. 
Pini et al., (2004), found that subjects with schizophrenia were much 
more compromised on insight dimension than psychotic mania.  
 Yen C F et al., (2005) studied 65 bipolar subjects and 74 
schizophrenic subjects considered to be in remission. He found that the 
relationship between admission insight scores correlated with medication 
adherence at 1 year follow up for bipolar patients but not for schizophrenia 
patients and concluded that building insight is an important step for 
establishing medication adherence in bipolar patients. 
Insight changes during hospitalization 
Studies    suggest   that  approximately  one- third  of   individuals   with 
schizophrenia   improve  in  awareness   of   their  illness  when  they  take  anti 
psychotic  medication.  Studies   also   suggest   that   a   larger   percentage   of 
individuals   with   bipolar   disorder  improve  on  medication (Jorgensen et al., 
1995). 
Weiler et al., (2000), found that many patients show improved insight as 
their acute symptoms improve. Insight improved across diagnoses during 
hospital care and significant relationship between improved symptoms and 
improved insight were obtained in both bipolar disorder & schizophrenia. He 
concluded that some aspects of insight were state related during exacerbation 
of illness in both patients with schizophrenia and bipolar disorder. 
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Chen et al., (2001), found that insight improved in over half of the 
patients during a psychotic episode and suggested that insight impairment was 
not entirely fixed and the possibility of intervention is open (Kemp et al., 1996) 
Ghaemi et al., (1995), concluded that insight did not appear to improve 
in general as the manic episode subsided. 
In the first meta-analysis of studies assessing insight in mania, Ghaemi 
et al., (2004), concluded that insight improved in bipolar disorder with 
resolution of the acute manic episode, suggesting that insight is state-dependent 
in bipolar disorder. He suggested that impaired insight be considered as part of 
the diagnostic picture of acute mania. 
Insight and severity of psychotic symptoms 
The relationship between unawareness of illness and severity of 
psychopathology in schizophrenia remained unclear. Some early studies 
examining the relationship have found these dimensions to be both inversely 
correlated (Small et al., 1965) and positively correlated (Whitman and Duffey 
1961). Later reports indicated that they are independent of each other (Bartko 
et al., 1988; McEvoy et al., 1989b). 
But more recent reports have shown that more severe psychiatric 
symptoms are seen in patients with poor insight, both in schizophrenia and 
mania. 
 Williams et al., (2002), found that severity of symptoms were 
significantly associated with insight in schizophrenia and bipolar mood 
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disorder. These results are consistent with the notion that poor insight is 
associated with severe illness. 
Francis J L et al., (2001), also found that greater insight was associated 
with less severe psychiatric symptoms. He also showed that greater insight was 
associated with better overall social skill, less observed strangeness and greater 
self-disclosure of one's mental illness. 
Insight and overall level of functioning 
An association between poorer insight and poorer overall level of 
psychosocial functioning in schizophrenia as measured by GAS (Global 
Assessment Scale) was shown by Amador et al., (1994). 
Attempts at improving poor insight 
There are very few reports in psychiatric literature examining directly 
the relationship between specific interventions and changes in insight. Attempts 
made in neurological disorders to treat problems of self-awareness serve as a 
useful model. McGlynn & Schacter, (1989), state that in severe forms of 
anosognosia, even repeated attempts to demonstrate deficits to the patients are 
ineffective. Glisky and Schacter, (1987), suggested that extreme repetition is 
necessary in training brain-damaged patients with memory impairments. 
Prigatano and Fordyce, (1986), found that frontal lobe dysfunction patients 
could be made to improve self-perception, whereas therapies were ineffective 
in temporal lobe and deep brain damaged patients. The implications of such 
works provide important guidelines for schizophrenia in which both frontal and 
temporal lobe lesions are postulated. 
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Partially successful attempts to modify delusional beliefs (Watts et al., 
1973; Milton et al., 1978) and at patient education (Lin et al., 1979; Brown       
et al., 1987) offer indirect evidence that some forms of knowledge about their 
illness can be modified in patients with Schizophrenia. Seltzer et al., (1980), 
observed that psychoeducated patients had better treatment compliance 
compared to those who were not.  
More recently, Cognitive Behavioral Therapy (CBT) has also shown 
potential in treating specific aspects of schizophrenia. Several authors 
(Rickelman, 2004; Lele and Joglekar, 1998) have shown that CBT improves 
Wisconsin Card Sorting Test (WCST) scores in schizophrenia patients. The 
WCST, as previously stated, is an accepted measure of frontal lobe cognitive 
functioning. Thus, if hypotheses linking certain aspects of insight to frontal 
lobe regions are correct, an improvement in WCST scores might well correlate 
with an improvement of insight.            
David, (1990) rightly concluded that as clinician rediscover the concept 
of insight they will feel more inclined to encourage patients to rediscover it too, 
allowing them to play a more active role in recovery. 
Insight in bipolar disorder- mania 
Ghaemi et al., (1995), examined the clinical correlates of lack of insight 
in bipolar disorder in 28 acutely manic patients and concluded that like 
schizophrenia, bipolar disorder appears to be a condition in which poor insight 
is a prominent characteristic. He also found that the mean scores of insight 
improved only slightly from admission to discharge despite marked 
improvement in other psychiatric symptoms. However, Ghaemi et al., (2004) in 
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a meta- analysis, states that insight improves in bipolar disorder with resolution 
of the acute manic episode, suggesting that insight is state dependent in bipolar 
disorder.  
Yen C F, (2003), assessed 33 mania patients during the manic state and 
subsequently during recovery and found that insight can improve, remain 
unchanged or decline during recovery from manic episodes. He also concluded 
that adequate treatment of manic symptoms is the first step toward managing 
insight impairment. 
Lam D, et al., (1997), did a cross sectional study in 40 bipolar patients 
who were not in acute manic episode and found that the patients' level of social 
functioning was related to their level of insight, and to how well they coped 
with the prodromes of mania and whether they could detect prodromes of 
depression. The results suggest that it is worth exploring ways of teaching 
patients to monitor their moods and to promote insight and good strategies for 
coping with their prodromes. 
In a study done by Dell Osso and Pini, (2002), in bipolar patients, they 
found that patients with mania showed significantly poorer insight compared 
with mixed mania, bipolar depression and unipolar depression. 
Ghaemi et al., (2000), performed a study to assess the relationship 
between impairment of insight and the long-term outcome in affective and 
anxiety disorders in 101 treated patients. Outcome was prospectively assessed 
with the Clinical Global Impression (CGI) and Global Assessment of 
Functioning (GAF) rating scales. The mean follow-up period was 3.9 months. 
They found that initial impairment of insight did not correlate with poor 
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outcome. However, improvement in insight correlated with good outcome, 
particularly in bipolar disorder type I. Insight was similarly impaired in bipolar 
and unipolar major depressive disorders, and more so than in anxiety disorders. 
An association between a lack of improvement in insight and a poor outcome, 
most significantly in bipolar disorder type I, was observed in this sample. They 
found a greater relative impairment of insight in mood versus anxiety disorders. 
Pallanti, (1999), investigated the awareness of illness and subjective 
cognitive complaints of 57 patients with either bipolar I disorder or bipolar II 
disorder during a phase of clinical stabilization. He found that patients with 
bipolar II disorder had significantly lesser insight and a higher level of 
subjective complaints than patients with bipolar I disorder. He concluded that 
severe deficits in self-awareness may constitute a distinguishing 
psychopathological characteristic of patients with bipolar II disorder. He also 
suggested that further studies were required to determine if there were 
associated neuropsychological dysfunctions.  
The questions posed to us:  
1. Are there differences in insight deficits between schizophrenia and 
mania? 
2. Is the severity of psychotic symptoms correlated with poorer insight? 
3. Is poor insight correlated with poor psychosocial functioning? 
4. Does insight improve during hospitalization and treatment, as the acute 
psychotic symptoms resolve in schizophrenia & mania? 
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AIM 
1. To describe the various components (dimensions) of insight.  
2. To measure the prevalence of insight in schizophrenia and mania. 
3. To find the relationship between insight and severity of psychosis.  
4. To find the relationship between insight and overall level of functioning. 
5. To study the change that occurs in insight during hospitalization and 
treatment. 
6. To clarify if insight deficits differ in the two groups-schizophrenia and 
mania. 
HYPOTHESIS 
1. There is no difference in the insight deficits between schizophrenia and 
mania. 
2. Poorer the insight, more severe the psychotic symptoms in both 
schizophrenia and mania. 
3. Poorer the insight, poorer the psychosocial functioning in both 
schizophrenia and mania 
4. Insight improves during hospitalization and treatment in both 
schizophrenia and mania. 
5. Better the education of the schizophrenia and mania patients, better the 
insight. 
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6. Longer the duration of illness in schizophrenia, better the insight. 
7. Greater the number of episodes in mania, better the insight. 
8. Schizophrenia and mania patients with prior treatment have better 
insight as compared to those who were never treated. 
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MATERIALS AND METHODS 
This is a descriptive study, of naturalistic design done in the acute ward 
of Institute of Mental Health.  Patients attending the out patient department at 
Institute of Mental Health who were psychotic and required admission and 
hence hospitalized in the acute ward (family ward) between November 2005 
and February 2006 were studied. 
Inclusion Criteria 
1. Of them 30 consecutive patients who satisfied the ICD-10 criteria for 
schizophrenia were compared with 30 consecutive patients who satisfied the 
ICD-10 criteria for bipolar affective disorder- current episode mania. The 
diagnoses were done by two persons (investigator and a consultant psychiatrist) 
independently. 
2. Age greater than 16 years. 
Exclusion criteria 
1. Substance induced psychosis 
2. Epilepsy 
3. Dementia 
4. Cerbrovascular disease. 
5. Patients not communicative and hence with whom a meaningful 
interview was not possible. 
Informed consent was obtained.  
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The instruments namely semi structured proforma for sociodemographic 
and clinical variables, the scale to assess unawareness of mental disorder, brief 
psychiatric rating scale and global assessment of functioning scale were 
administered twice, first at the time of admission and again at the time of 
discharge. 
During the stay in hospital, the patients were accompanied by a close 
relative. Treatment given was mainly pharmacotherapy- antipsychotic drugs 
were used to treat schizophrenia and a combination of antipsychotics and mood 
stabilizers were used for mania. Pareteral injections of haloperidol, lorazepam 
and promethazine were also used whenever necessary. No attempt was made to 
control the treatment variables, as our aim was to do a naturalistic study that 
would give a real world picture of evolution of symptoms. 
Instruments used 
1. A semi structured proforma for sociodemographic profile and relevant 
clinical data. 
2. Brief Psychiatric Rating Scale (BPRS). 
3. Global Assessment of Functioning scale (GAF). 
4. Scale to Assess Unawareness of Mental Disease (SUMD). 
1. Semi structured proforma for Sociodemographic and relevant Clinical 
data 
The proforma was used to collect data such as name, age, sex, outpatient 
and inpatient numbers, marital status, employment status, details of occupation, 
religion, education, socioeconomic status, type of family and handedness. 
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Clinical data that were recorded include the duration of illness (for 
schizophrenia) and number of episodes (for mania), details of prior treatment 
and details of current treatment. 
2. Scale to assess Unawareness of Mental Disorder (SUMD) 
SUMD has of all 74 items. The first item measures current awareness of 
mental disorder (referred hereafter as “item 1c”). The second item measures 
awareness of mental disorder in the past (referred hereafter as “item 1p”). The 
third item measures current awareness of achieved effects of medication 
(referred as “item2c”). The fourth item measures awareness of achieved effects 
of medication in past (“item2p”). The fifth items measures current awareness of 
social consequences of mental disorder (“item3c”). The sixth item measures 
past awareness of social consequences of mental disorder (“item3p”). Thus it 
has six general items (“items 1-3, c & p”). 
These 6 general items approximate the 3 most widely used definitions of 
insight - global awareness of mental disorder, awareness of achieved effects of 
medication and awareness of social consequences of having a mental disorder 
and included are both the past and current time periods. 
The remaining 68 items are grouped into 17 groups. The 17 signs and 
symptoms taken into consideration are 
4) Hallucination  
5) Delusion  
6) Thought disorder  
7) Inappropriate affect  
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8) Unusual appearance  
9) Stereotypic behavior  
10) Poor social judgment  
11) Poor control of aggressive impulses  
12) Poor control of sexual impulses  
13) Alogia  
14) Flat affect  
15) Avolition- Apathy  
16) Anhedonia /Asociality  
17) Poor attention  
18) Confusion-Disorientation  
19) Unusual eye contact  
20) Poor social relationships  
For each of these 17 items, (hereafter referred to as “items 4-20 of 
SUMD”) current awareness, retrospective awareness, current attribution and 
retrospective attribution were assessed. Awareness is the recognition of signs 
or symptoms of illness, while attribution refers to explanations about the cause 
or source of the signs or symptoms. 
All scores range from 1-5 with scores indicating awareness or 
attribution. It is to be noted here that higher the SUMD score, higher the 
unawareness. A score of 1 would mean patient is aware. A score of 3 would 
mean patient was somewhat aware. A score of 5 would mean patient is 
unaware. A score of 0 is given, when the symptom is absent or not applicable 
(for items 4-20). Thus higher scores in SUMD imply poorer insight. 
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Although the scale to assess unawareness of mental disorder is meant to 
be comprehensive it was designed so that any scale or summary item can be 
used independent of the others depending on the goals of the investigation. 
The scale was put to test by Amador et al., in 1993. The scale item 
variability was high and normally distributed supporting the contention that 
insight can be rated on a continuous rather than a dichotomous scale. 
The insight ratings on the mental status examination and the Hamilton 
depression rating scale were highly correlated with rating on the general item 
of the scale to assess unawareness of mental disorder suggesting that these 
items have convergent variability with other global measures of insight into 
mental disorder. 
Amador, (1993), showed that the subscales were largely independent of 
each other and that both the distinction between “awareness and attribution” 
and “current and retrospective” assessment are valid.  He also established that 
the “current” subscales measure a phenomenon which differs in many respects 
from that assessed by the retrospective subscales and insight evaluation of the 
mental status examination.  
The Scale to Assess Unawareness of Mental Disorder has good 
reliability and validity and has certain advantages over previous measures of 
insight, suggesting the usefulness of a multidimensional view of this complex 
concept.  
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3. Global Assessment of Functioning scale (GAF)  
This is the fifth axis in DSM-IV. It has its origins in Health sickness 
rating done by Luborsky in 1962 and considered to be the first effort to 
evaluate psychological health and illness, utilizing a 100-point scale. Later the 
scale was divided into groups called levels in the global assessment scale and 
in 1987, after some modifications, became the global assessment of functioning 
scale and Axis-V of the DSM-IIIR and DSM-IV. 
The GAF is used to assess psychiatric patients at the time of admission 
to an inpatient or outpatient program as a part of multiaxial evaluation as 
recommended by the American Psychiatric Association- DSM classifications. 
The GAF is a 100-point single item scale with values ranging from 1 to 
100, representing the hypothetically sickest person to the healthiest. The scale 
is divided into equal point intervals with 81-90 and 91- 100 for individuals who 
exhibit superior functioning. Most outpatients will receive ratings between 31-
70 and most inpatients between 1- 40. 
The information needed to assign a numeric value to the health of a 
patient comes from the clinical evaluation done and other sources. The 
reliability of the GAF ranges from 0.62 to 0.82. (Endicott & Fliess et al., 1976). 
4. The Brief Psychiatric Rating Scale (BPRS) 
The BPRS developed by J.E.Overall and D.R.Gorham is a very widely 
used relatively brief scale that measures major psychotic and non-psychotic 
symptoms in individuals with a major psychiatric disorder particularly 
schizophrenia. The eighteen item BPRS is perhaps the most researched item in 
 31
psychiatry. Eighteen symptom constructs are listed for rating on a seven points 
scale (0-not present; 6-most severe). The rating is based upon observation made 
by the clinician / rater during a 15 to 30 minutes interview (items which 
measure tension, emotional withdrawal, mannerism and posturing, motor 
retardation and uncooperativeness) and subject’s verbal report (items which 
measure conceptual disorganization, unusual thought content, anxiety, guilt 
feelings, grandiosity, depressive mood, hostility, somatic concern, 
hallucinatory behavior, suspiciousness and blunted affect). The other two items 
are excitement and disorientation.  
The limitations of the BPRS include somewhat ambiguous criteria for 
the various levels of severity with potential for overlap in some of the items 
that are most broadly defined. Strengths of the scale include its brevity, ease of 
administration, wide use and well-researched status. 
The BPRS is appropriate for evaluating baseline psychopathology, 
clinical outcome and treatment response with the frequency of repeat 
administrations at the discretion of clinical investigator. 
The scale was developed primarily for inpatient populations, but it may 
also be utilized for outpatients.  
 A reliability co-efficient of 0.56 to 0.67 has been reported by authors 
(Overall & Gorham, 1962). 
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STATISTICAL ANALYSIS 
The results were analyzed using SPSS package. 
The t- test was used to compare continuous variables and chi-square test 
was used to compare categorical variables.  
Pearson’s Correlation Coefficient was calculated to find the relationship 
between insight and psychotic severity / global functioning. 
ANOVA (Analysis Of Variance) was used to compare the mean insight 
scores between the 3 groups (regularly treated, irregularly treated and not 
treated). 
Statistical significance was assumed at a p value<0.05. 
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RESULTS 
There were 30 Schizophrenia patients and 30 mania patients. 
Table1: Sociodemographic variables of the patients 
Socidemographic variable Schizophrenia Mania p value 
Age- Mean 28.6 33 0.078 
Sex- Males 25(83%) 25(83%) 1.00 
Marital status- Married 8(26.7%) 12 (40.0%) 0.39 
Religion- Hindu 27(90.0%) 25(83.3%) 0.08 
Handedness- Left 27(90.%) 30(100.0%) 0.08 
Family type- Joint 16(53.3%) 10(33.3%) 0.12 
Prior treatment– Nil 13(43.3) 13(43.3) 0.55 
 
The mean age of the schizophrenia patients was 28.6 and that of the 
mania patients was 33 years. 83. 3 % of patients were male. Of the 
schizophrenia patients 8 (26.7%) were married and of the mania patients 12 
(40%) were married. Of the schizophrenia patients, 27 were Hindu and 3 were 
Muslims. Of the mania patients, 25 were Hindus, 1was Muslim and 4 were 
Christians. Of the schizophrenia patients, 3 were left-handed and of the mania 
patients none were left-handed. Of the schizophrenia patients, 53 % were living 
in a joint family, whereas of the mania patients 33.3% were living in a joint 
family. Of the schizophrenia patient, 43.3% were not on treatment and of the 
mania patients, 43.3% were not on treatment. The differences in these 
sociodemographic variables were not statistically significant between these two 
groups. 
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Table 2:Employment status of the patients 
Schizophrenia Mania Total 
Employment 
Count (%) Count (%) Count (%) 
Unemployed 25 (83.3) 10 (33.3) 35 (58.3) 
Employed 5 (16.7) 20 (66.7) 25 (41.7) 
*p< .001 
Of the schizophrenia patients, 83.3% were unemployed whereas only 
33.3% of the mania patients were unemployed. This difference was statistically 
significant with a p value<0.001, when analyzed using the chi-square test. 
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Insight in schizophrenia vs mania at admission: 
Table3. Prevalence of insight at admission 
schizophrenia mania 
SUMD  
item 1 
(aware) 
3 
(somewhat 
aware) 
5 
 (unaware) 
1 
 (aware) 
3 
(somewhat 
aware) 
5 
 (unaware) 
p 
value 
1c 8(26.7%) 1(3.3%) 21(70%) 3(10%) 2(6.7%) 25(83.3%) 0.228 
2c 15(50%) 3(10%) 12(40%) 11(36.7%) 3(10.0%) 16(53.3%) 0.552 
3c 12(40%) 1(3.3%) 17(56.7%) 9(30.0%) 2(6.7%) 19(63.3%) 0.646 
1p 11(36.7%) 0(0%) 19(63.3%) 9(30%) 3(10%) 18(60%) 0.19 
2p 15(50%) 3(10%) 12(40)% 11(36.7%) 3(10%) 16(53.3%) 0.55 
3p 12(40%) 1(3.3%) 17(56.7%) 9(30.0%) 3(10.0%) 18(60%) 0.48 
SUMD- scale to assess unawareness of mental disorder; 1-mental disorder; 2-
medication efficacy; 3-consequences; c- current; p-past. 
 a) Prevalence of insight at admission based on SUMD item 1c (current 
awareness of mental illness) 
Of the schizophrenia patients, 70% were unaware, 3.3% were somewhat 
aware and 26.7 % were aware of current mental illness. 
Of the mania patients, 83.3% patients were unaware, 6.7% were 
somewhat aware, and   3 % were aware of current mental disorder. 
These differences were not significant with a p value of .228, when 
analysed using the chi-square test. 
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b)      Prevalence of insight at admission based on SUMD item 2c (current 
awareness of achieved effects of medication) 
Of the schizophrenia patients, 40 % were currently unaware, 10% were 
somewhat aware, and 50% were aware of achieved effects of medication. Of 
the mania patients 53.3% were currently unaware, 10% were somewhat aware 
of achieved effects of medication and 36.7% were aware of achieved effects of 
medication. These differences were not statistically significant with a p- value 
of 0.55, when analysed using the chi-square test. 
c) Prevalence of insight at admission based on SUMD item 3c (current 
awareness of social consequences of mental disorder) 
Of the schizophrenia patients, 56.7% were currently unaware, 3.3% 
were somewhat aware and 40 % were aware of social consequences of mental 
disorder. 
Of the mania patients, 63.3% were currently unaware, 6.7% were 
somewhat aware and 30% were aware of the social consequences of mental 
disorder. These differences were not statistically significant with a p value of 
0.646, when analysed using the chi-square test. 
Prevalence of retrospective insight at admission: 
d) Prevalence of retrospective insight at admission based on SUMD 
item 1p (awareness of illness of mental disorder in the past) 
Of schizophrenia patients, 63.3% were unaware and 36.7% were aware 
of mental disorder in the past. 
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Of mania patients, 60% were unaware, 10% were somewhat aware, and 
30% were aware of mental disorder in the past. 
These differences were not statistically significant with a p value 0.19 
when analyzed using the chi-square test. 
b) Prevalence of retrospective insight at admission based on SUMD 
item 2p (awareness of achieved effects of medication in the past) 
Of the schizophrenia patients, 40% were unaware, 10% were somewhat 
aware and 50% were aware of achieved effects of medication in the past. 
Of the mania patients 53.3% were unaware, 10% were somewhat aware, 
and 36.7% were aware of achieved effects of medication in the past.These 
differences were not statistically significant with a p value of .55 when 
analysed using the chi-square test. 
c) Prevalence of retrospective insight at admission based on SUMD 
item 3p (awareness of social consequences of mental disorder in the 
past) 
Of the schizophrenia patients, 56.7% were unaware, 3.3% were 
somewhat aware and 40% were aware of the social consequences of mental 
disorder in the past. 
Of mania patients, 60% were unaware, 10% were somewhat aware and 
30% were aware of the social consequences of mental disorder in the past. 
These differences were not statistically significant with a p value of .48, 
when analysed using the chi-square test. 
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Table 4.Comparison of insight score at admission in  
schizophrenia and mania 
Schizophrenia    
(n = 30) 
Mania             
(n = 30) 
Unawareness of 
(SUMD item) Mean S D Mean S D      t df p value
Mentaldisorder (1c) 3.87 1.80 4.47 1.28 -1.49 58 0.141 
Mental disorder (1p) 3.53 1.96 3.60 1.83 -0.14 58 0.892 
Consequences (2c) 2.80 1.92 3.33 1.90 -1.08 58 0.284 
Consequences (2p) 2.80 1.92 3.33 1.90 -1.08 58 0.284 
Medication      
Efficacy (3c) 3.33 1.97 3.67 1.84 -0.68 58 0.502 
Medication       
Efficacy (3p) 3.33 1.97 3.60 1.83 -0.54 58 0.589 
c- current; p- past; SUMD- scale to assess unawareness of mental disorder. 
The mean insight scores on the first 6 items of SUMD 1c & 1p         
(awareness of mental disorder currently and in the past), 2c & 2p (awareness of 
achieved effects of medication currently and in the past), 3c & 3p (awareness 
of social consequences of mental disorder currently and in the past), did not 
show any statistically significant differences at p <. 05, when analysed using 
the t-test. 
Similarly the insight scores of the remaining items (4-20) of SUMD also 
did not show any statistically significant differences 
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 Insight in schizophrenia vs mania at discharge 
Table – 5. Prevalence of insight at discharge in schizophrenia and mania 
Schizophrenia mania 
SUMD 
Item 
 
1 
(aware) 
3 
(somewh
at aware) 
5 
(unaware) 
1 
(aware) 
3 
(somewha
t aware) 
5  
(unaware) 
p 
value 
1 c 10(33.3%) 10(33.3% 10(33.3%) 7(23.3%) 6(20.0%) 17(56.7%) 0.18 
2 c 25(83.3%) 3(10.0%) 2(6.7%) 25(83.3%) 0 5(16.7%) 0.11 
3 c 15(50.0%) 3(10.0%) 12(40.0%) 19(63.3%) 4(13.3%) 7(23.3%) 0.381 
1 p 11(36.7%) 8(26.7%) 11(36.7%) 13(43.3%) 5(16.7%) 12(40%) 0.48 
2 p 22(73.3%) 3(10%) 5(16.7%) 22(73.3%) 0 8(26.7%) 0.15 
3 p 15(50%) 4(13.3%) 11(36.7%) 19(63.3%) 4(13.3%) 7(23.3%) 0.5 
SUMD-Scale to assess unawareness of mental disorder; 1- mental 
disorder; 2-medication efficacy; 3-consequences; c-current and p-past 
a. Prevalence of insight at discharge based on SUMD item 1c (current 
awareness of mental disorder 
Of the schizophrenia patients, 33.3% were currently  unaware, 33.3% 
were somewhat aware and 33.3% were aware of mental disorder at the time of 
discharge. 
Of the mania patients, 56.7% were unaware, 20% were somewhat aware 
and 23.3% were aware of mental disorder. These differences were not 
significant with a p value of 0.18 when analyzed using the chi-square test. 
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b. Prevalence of insight at discharge based on SUMD item 2c (current 
awareness of achieved effects of medication) 
Of the schizophrenia patients, 6.7 % were currently unaware, 10% were 
some what aware and 83.3% were aware of achieved effects of medication. 
Of the mania patients 16.7% were currently unaware, 83.3% were aware 
of achieved effects of medication. These differences were not statistically 
significant with p value 0.12, when analysed using the chi-square test. 
c. Prevalence of insight at discharge based on SUMD Item3c (current 
awareness of social consequences of mental disorder) 
Of the schizophrenia patients, 40% were currently unaware, 10% were 
somewhat aware and 50% were aware of the social consequences of mental 
disorder. Of the mania patients, 23.3% were currently unaware, 13.3% were 
somewhat aware and 63.3%were aware of the social consequences of mental 
disorder. 
These differences were not significant with a p value of 0.381, when 
analyzed using the chi-square test. 
Retrospective insight at discharge 
d) Prevalence of retrospective insight at discharge based on SUMD 
item 1p (awareness of mental disorder in past) 
Of the schizophrenia patients, 36.7% were unaware, 26.7% were 
somewhat aware and 36.7%were aware of mental disorder in past. 
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Of the mania patients, 40% were unaware, 16.7% were somewhat aware 
and 43.3% were aware of mental disorder in past. 
These differences were not statistically significant with a p value of 
0.48, when analysed using the chi-square test. 
e)     Prevalence of retrospective insight at discharge based on SUMD   
item 2p (awareness of achieved effects of medication in the past) 
Of schizophrenia patients, 16.7% were unaware, 10% were somewhat 
aware and 73.3% were aware of the achieved effects of medication in the past. 
Of mania patients, 26.7% were unaware and 73.3% were aware of 
achieved effects of medication in past. 
These differences were not statistically significant with a p value of 
0.15, when analysed using the chi-square test. 
f. Prevalence of retrospective insight at discharge based on SUMD 
item 3p (awareness of social consequences of mental disorder in 
past) 
Of schizophrenia patients, 36.7% were unaware, 13.3% somewhat aware 
and 50% were aware of the social consequences of mental disorder in past. 
Of mania patients, 23.3% were unaware, 13.3% were somewhat aware 
and 63.3% were aware of the social consequences of mental disorder. 
These differences were not statistically significant at p= 0.05, when 
analyed using the chi-square test. 
 42
 
Table 6.a. Comparison of insight score in schizophrenia vs mania at 
discharge for items 1-3 in SUMD 
Schizophrenia 
(n=30) 
Mania  
(n = 30) Unawareness of 
(SUMD item) 
Mean S.D Mean S.D 
t df p value 
Mental disorder 
(1c) 3.00 1.66 3.67 1.69 -1.54 58 0.129 
Mental disorder 
(1p) 3.00 1.74 2.93 1.86 0.14 58 0.886 
Consequences(2c) 1.47 1.14 1.67 1.52 -0.58 58 0.565 
Consequences(2p) 1.87 1.55 2.07 1.80 -0.46 58 0.646 
Medication 
Efficacy (3c) 2.80 1.92 2.20 1.71 1.28 58 0.206 
Medication 
Efficacy (3p) 2.73 1.87 2.20 1.71 1.15 58 0.254 
c- current; p-past SUMD-Scale to assess unawareness of mental disorder 
The insight scores on SUMD item1-3, c & p for schizophrenia and 
mania were compared and did not show any statistically significant difference, 
when analyzed using the t-test. 
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Table 6.b. Comparison of insight score in schizophrenia v mania at 
discharge for the items 4 –20 in SUMD 
Schizophrenia 
(n=30) 
Mania  
(n=30) 
t df p value Unawareness of        
(SUMD Item) 
mean S.D mean S.D    
Hallucination (c-aw)(4) 0.63 1.07 0.37 0.67 1.16 58 0.251 
Hallucination (p-aw)(4) 1.07 1.31 0.47 0.97 2.01 58 0.049 
Hallucination (c-at)(4) 1.37 2.08 0.63 1.43 1.59 58 0.116 
Hallucination p-at (4) 2.20 2.19 1.00 1.70 2.37 58 0.021 
Poor Social relationships (c-
aw) (20) 1.57 1.59 1.33 1.58 0.57 58 0.571 
Poor Social relationships (p-
aw) (20) 1.57 1.59 2.17 2.05 -1.27 58 0.211 
Poor Social relationships 
(c-at) (20) 3.57 1.94 2.13 2.08 2.76 58 0.008 
Poor Social relationships 
(20p-at) (20) 3.57 1.94 2.13 2.08 2.76 58 0.008 
aw- awareness; at- attribution; c-current; p-past. 
On analyzing the item 4 of SUMD, using the t-test, it was found that 
schizophrenia patients had a poorer retrospective insight (higher the sumd 
score, poorer the insight) with respect to both awareness as well as attribution 
of hallucinations, compared to patients of mania  
On analyzing the item 20 of SUMD, using the t-test, it was found that 
schizophrenia patients had poorer current & retrospective attribution of poor 
social relationships to mental disorder, compared to patients of mania. 
The comparison of rest of the items between 4-20 of SUMD did not 
show any statistically significant difference. 
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Table7.a.Insight in schizophrenia at admission VS discharge  or items1-3 
of SUMD:  
Admission Discharge Unawareness of (SUMD 
Item) Mean S D Mean S D 
t df p value
Mental disorder (1c) 3.87 1.80 3.00 1.66 2.64 29 0.013 
Mental disorder (1p) 3.53 1.96 3.00 1.74 1.44 29 0.161 
Consequences (2c) 2.80 1.92 1.47 1.14 4.13 29 0.000 
Consequences (2p) 2.80 1.92 1.87 1.55 2.73 29 0.011 
Medication Efficacy (3c) 3.33 1.97 2.80 1.92 1.55 29 0.133 
Medication Efficacy (3p) 3.33 1.97 2.73 1.87 1.87 29 0.071 
c-current; p-past. 
Comparing the insight scores at admission and at discharge, using the t-
test, it was found that insight at discharge was better (lower the SUMD score 
better the insight) for the item 1c, 2c, and 2p. 
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Table 7.b.Insight in schizophrenia at admission vs discharge for items 4-20 
of SUMD 
Admission Discharge Unawareness of  
(SUMD Item) Mean S D Mean S D 
t df p value 
Hallucination (c-aw)(4) 0.87 1.22 0.63 1.07 2.25 29 0.032 
Delusion (c-aw) (5) 1.67 1.73 0.97 1.45 2.50 29 0.018 
Thought disorder (c-aw)(6) 1.20 2.14 0.37 1.27 2.51 29 0.018 
Thought disorder (p-aw) (6) 1.03 2.03 0.40 1.28 2.22 29 0.035 
Thought disorder (c-at) (6) 1.17 2.15 0.37 1.27 2.40 29 0.05 
Thought disorder (p-at) (6) 1.17 2.15 0.47 1.36 2.30 29 0.029 
Aggression-(c-at)(11) 3.60 2.01 2.63 2.14 2.19 29 0.036 
Aggression(p-at)(11) 3.73 1.96 2.97 1.97 2.07 29 0.047 
Confusion(c-at)(18) 1.60 2.22 0.67 1.42 2.70 29 0.011 
c- current; p- past; aw- awareness; at- attribution. 
Of the remaining items between 4- 20 of SUMD, these items showed 
better insight at discharge than at admission. 
4c-aw (awareness of current hallucinations), 
5c-aw (awareness of current delusion), 
6 c & p, aw & at (awareness and attribution of thought disorder, current 
and past).  
11c & p-at (attribution of poor control of aggressive impulses to mental 
disorder, current & past) 
18 c-at (attribution of confusion to mental disorder) 
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Table8a. Insight in Mania at admission VS discharge for items 1-3 of 
SUMD 
Admission Discharge Unawareness of 
(SUMD Item) Mean S D Mean S D 
t df p value 
Mental disorder (1c) 4.47 1.28 3.67 1.69 2.84 29 0.008 
Mental disorder (1p) 3.60 1.83 2.93 1.86 1.78 29 0.086 
Consequences (2c) 3.33 1.90 1.67 1.52 4.48 29 0.000 
Consequences (2p) 3.33 1.90 2.07 1.80 2.99 29 0.006 
MedicationEfficacy 
(3c) 3.67 1.84 2.20 1.71 3.34 29 0.002 
MedicationEfficacy 
(3p) 3.60 1.83 2.20 1.71 3.25 29 0.003 
c- current; p-past. 
Insight was better with statistical significance in the SUMD items 1c, 
2c, 2p, 3c, and 3p at discharge compared with admission, when analysed using 
the t-test. 
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Table8b. Insight in Mania at admission VS discharge for items 4-20 of 
SUMD: 
Admission Discharge 
Unawareness of (SUMD 
Item) Mean S D Mean S D t df 
p 
value 
Hallucination(c-at)(4) 1.50 2.22 0.63 1.43 2.77 29 0.010 
Aggression(c-aw)(11) 1.77 1.48 1.13 1.20 2.92 29 0.007 
Aggression( p-aw)(11) 1.77 1.63 1.27 1.11 2.06 29 0.049 
Aggression (c-at)(11) 4.03 1.71 2.40 1.99 4.70 29 0.000 
Aggression (p-at)(11) 3.70 1.97 2.80 1.90 3.25 29 0.003 
Inattention(c-aw)(17) 1.53 2.10 0.73 1.14 2.53 29 0.017 
Inattention (p-at) (17) 1.47 2.19 0.50 1.28 2.35 29 0.026 
Confusion(c-at)(18) 1.27 2.16 0.60 1.25 2.07 29 0.048 
Confusion(p-at)(18) 0.93 1.93 0.00 0.00 2.65 29 0.013 
Poor Social relations (c-
at)(20) 3.20 2.27 2.13 2.08 2.40 29 0.023 
Poor Social relations ( p-
at)(20) 3.03 2.31 2.13 2.08 2.12 29 0.043 
aw- awareness;  at- attribution; c-current; p-past. 
Of the remaining items between 4-20 of SUMD, the following items 
were better at discharge compared to admission. 
item 4c-at i.e. current attribution of hallucination to mental disorder  
11c&p-aw&at i.e. awareness and attribution of poor control of 
aggressive impulses to mental disorder, current & past. 
17c-aw &17 p-at (current awareness and retrospective attribution of 
poor attention to mental disorder) 
18c&p-at (attribution of confusion to mental disorder, current &past) 
20c&p-at (attribution of poor social relationships to mental disorder, 
current&past) 
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Table 9a.Changes in BPRS and GAF during hospitalization in 
Schizophrenia: 
Admission Discharge 
Schizophrenia 
Mean S D Mean S D 
t df p value
BPRS 27.40 5.97 12.47 4.22 15.81 29 0.000
GAF 29.67 8.90 53.00 10.22 -13.86 29 0.000
 
Table 9b.Changes in BPRS and GAF during hospitalization in mania: 
Admission Discharge 
Mania 
Mean S D Mean S D 
t df p value 
BPRS 21.07 4.53 8.90 2.60 15.41 29 0.000 
GAF 29.33 11.12 58.67 10.74 -15.33 29 0.000 
 
Both in schizophrenia and in mania there was a statistically significant 
reduction in BPRS and improvement in GAF at discharge compared with at 
admission, when analyzed using the t-test. 
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Table 10.Correlation between severity of psychotic symptoms and 
unawareness at admission in Schizophrenia: 
Unawareness of 
(SUMD item) 
Mental 
disorder 
(1c) 
Medication 
efficacy 
(2c) 
Consequences
(3c) 
Correlation with 
BPRS 
-O.664** -0.191 -0.591** 
p 0.000 O.311 0.001 
** Significant at p<0.01 
In schizophrenia at admission, when correlation was analyzed between 
unawareness at admission and total BPRS score, we found a significant 
negative correlation between unawareness and BPRS. i.e. more the 
unawareness less severe the psychiatric symptoms. 
Table 11.Correlation between global functioning and unawareness at 
admission in Schizophrenia: 
Unawareness of 
(SUMD item) 
Mental 
disorder 
(1c) 
Medication 
efficacy 
(2c) 
Consequences
(3c) 
Correlation with 
GAF 
-0.413* -0.327 -0.387* 
p 0.023 0.078 .035 
 
Significant at p <0.05 
In schizophrenia, at admission, when Correlation was analyzed between 
global functioning and unawareness, we found a significant negative 
correlation, between unawareness and global functioning i.e. more the 
unawareness, less the global functioning. 
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Table12.Correlation between severity of psychotic symptoms and 
unawareness at admission in mania 
Unawareness of 
(SUMD item) 
Mental 
disorder 
(1c) 
Medication 
efficacy 
(2c) 
Consequences
(3c) 
Correlation with 
BPRS 
-0.125 0.406* -0.006 
p 0.512 0.026 0.977 
**Significant at p<0.05 
In mania, at admission, a significant positive correlation was seen 
between unawareness and psychotic severity.i.e more the unawareness, more 
the severity of psychotic symptoms. 
Table 13: Correlation between global functioning and unawareness at 
admission in Mania: 
c- current; p- past; SUMD- scale to assess unawareness of mental disorder. 
No significant correlation was seen between unawareness and global 
functioning at admission in Mania. 
 
 
Unawareness of 
(SUMD item) 
Mentaldisorder
(1c) 
Medication efficacy 
(2c) 
Consequences
(3c) 
Correlation with 
GAF 
0.12 -0.348 -0.112 
p 0.529 0.059 0.555 
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Table 14.Correlation between severity of psychotic symptoms and 
unawareness at discharge in schizophrenia: 
Unawareness of 
(SUMD item) 
Mentaldisorder 
(1c) 
Medication 
efficacy (2c) 
Consequences
(3c) 
Correlation with 
BPRS 
-0.147 0.226 -0.099 
p 0.437 0.230 0.604 
c- current; p- past; SUMD- scale to assess unawareness of mental disorder. 
No significant correlation was seen between unawareness and severity 
of psychotic symptoms in Schizophrenia at the time of discharge.  
Table 15.Correlation between global functioning and unawareness at 
discharge in Schizophrenia 
c- current; SUMD- scale to assess unawareness of mental disorder. 
No significant correlation was seen between unawareness and severity 
of psychotic symptoms in Schizophrenia at the time of discharge.  
 
 
Unawareness of 
(SUMD item) 
Mentaldisorder 
(1c) 
Medication 
efficacy (2c) 
Consequences
(3c) 
Correlation with 
GAF 
-0.325 -0.184 -0.250 
p 0.08 0.33 0.183 
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Table16.Correlation between severity of psychotic symptoms and 
unawareness at discharge in Mania 
Unawareness of 
(SUMD item) 
Mentaldisorder 
(1c) 
Medication 
efficacy (2c) 
Consequences
(3c) 
Correlation with 
BPRS 
0.220 0.506** 0.183 
p 0.244 0.004 0.334 
**Significant at p<0.01 
A significant positive correlation was seen between unawareness and 
psychotic severity.i.e more the unawareness, more the severity of psychotic 
symptoms, at discharge in Mania 
Table 17: Correlation between global functioning and unawareness at 
discharge in Mania 
c- current; SUMD- scale to assess unawareness of mental disorder. 
No significant correlation was seen between unawareness and global 
functioning at discharge in mania. 
 
 
Unawareness of 
(SUMD item) 
Mental disorder 
(1c) 
Medication efficacy 
(2c) 
Consequences
(3c) 
Correlation with 
GAF 
0.203 -0.198 -0.023 
p 0.282 0.295 0.906 
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Table18a.The association between insight and education 
<10th std (n= 41) >10thstd (n= 19) 
Unawareness 
of         
(SUMD item) 1 (aware) 
3 (some 
what 
aware) 
5 
(unaware) 
1  
(aware) 
3 (some 
what 
aware) 
5 
(unaware) 
p 
value 
(χ2) 
Mental 
disorder (1c) 8(19.5%) 3(7.3%) 30(73.2%) 3(15.8%) 0 16(84.2%) 0.429 
Medication 
efficacy (2c) 18(43.9%) 3(7.3%) 20(48.8%) 8(42.1%) 3(15.8%) 8(42.1%) 0.587 
Consequences 
        (3c) 15(36.6%) 2(4.9%) 24(58.5%) 6(31.6%) 1(5.3%) 12(63.2%) 0.931 
n- number; c- current; SUMD- scale to assess unawareness of mental disorder. 
The entire population, was divided into those educated less than 10 th 
std and those educated more than 10 th and insight between these two groups 
compared ,at admission, using the chi-square test, as shown above but no 
significant difference was present in insight between these two groups 
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Table19a.the association between Insight and number of episodes in mania 
at admission 
Episode Number 
< = 2 (n = 15) > 2 (n = 15)
Unawareness of 
(SUMD Item) 
Mean S D Mean S D 
t df p value
mental disorder(1c) 5.00 0.00 3.93 1.67 2.48 28 0.020 
mental disorder (1p) 4.33 1.45 2.87 1.92 2.36 28 0.025 
Consequences(2c) 4.07 1.67 2.60 1.88 2.26 28 0.032 
Consequences(2p) 4.20 1.66 2.47 1.77 2.77 28 0.010 
Medication Efficacy (3c) 3.93 1.67 3.40 2.03 0.79 28 0.438 
Medication Efficacy (3p) 4.20 1.47 3.00 2.00 1.87 28 0.072 
c- current; p- past; SUMD- scale to assess unawareness of mental disorder. 
The group of mania was divided into those less than 2 episodes and 
those greater than 2 episodes. The differences in insight between these two 
groups compared. 
It was found that mania patients with more than 2 episodes had a better 
insight compared to patients with less than 2 episodes at admission in the items 
1c 1p 2c 2p of sumd. With statistical significance of p value less than 0.05 (t-
test) 
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Table19b.the association between Insight and number of episodes in mania 
at discharge 
Episode Number 
< = 2 (n = 15) > 2 (n = 15)Unawareness of 
(SUMD Item) Mean S D Mean S D t df p value 
Mental disorder(1c) 4.33 1.23 3.00 1.85 2.32 28 0.028 
Mental disorder (1p) 3.67 1.80 2.20 1.66 2.32 28 0.028 
c- current; p- past; SUMD- scale to assess unawareness of mental disorder. 
The comparison of these two groups at discharge showed that those with 
greater than 2 episodes had a better insight than those with less than 2 episodes 
in item 1c and 1p of SUMD.(t-test) 
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Table19c.the association between Insight and number of episodes in mania 
at discharge based on item 11 SUMD 
Episode Number 
< = 2 (n = 15) > 2 (n = 15) Unawareness of (SUMD Item) 
Mean S D Mean S D 
t df p value
Aggression  
(c-aw)(11) 1.60 1.50 0.67 0.49 2.29 28 0.030 
Aggression  
(p-aw)(11) 1.60 1.50 0.93 0.26 1.69 28 0.101 
Aggression  
(c-at)(11) 3.20 1.93 1.60 1.76 2.37 28 0.025 
Aggression  
(p-at)(11) 3.20 1.93 2.40 1.84 1.16 28 0.256 
aw- awareness; at- attribution; c- current; p-past; SD-standard deviation. 
Of the remaining items between 4-20 Of SUMD, current awareness and 
current attribution of poor control of aggressive impulses (item11 of SUMD), 
was better in mania patients with greater than 2 episodes. 
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Table20.The association between Insight and duration of schizophrenia at 
admission 
Duration 
< 2 > 2 
Unawareness of 
(SUMD Item) 
N Mean S D N Mean S D
t df p value
Mental disorder 
(1c) 13 3.9 1.8 17 3.8 1.9 0.15 28 0.883 
Mental disorder 
(1p) 13 3.5 2.0 17 3.6 2.0 -0.17 28 0.864 
Consequences (2c) 13 3.2 1.9 17 2.5 1.9 0.88 28 0.387 
Consequences (2p) 13 3.2 1.9 17 2.5 1.9 0.88 28 0.387 
Medication 
Efficacy (3c) 13 3.5 2.0 17 3.2 2.0 0.31 28 0.761 
Medication 
Efficacy (3p) 13 3.5 2.0 17 3.2 2.0 0.31 28 0.761 
c- current; p- past; SUMD- scale to assess unawareness of mental disorder. 
The schizophrenia patients were divided as those with less than 2 years 
duration and those with greater than 2 years duration of illness. Insight did not 
vary significantly between these two groups with respect to the first 3 items in 
SUMD (t-test). 
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Table 21a.The association between insight and prior treatment in 
schizophrenia at admission 
Nil (n= 13) 
Regular  
(n = 10) 
Irregular 
(n=7) Unawareness of 
(SUMD Item) Mean S D Mean S D Mean S D 
p 
value
Mental disorder (1c) 4.38 1.50 3.40 2.07 3.57 1.90 0.391
Mental disorder (1p) 4.38 1.50 3.00 2.11 2.71 2.14 0.108
Consequences (2c) 3.15 2.08 2.80 1.99 2.14 1.57 0.548
Consequences (2p) 3.46 2.03 2.40 1.90 2.14 1.57 0.254
Medication Efficacy (3c) 3.77 1.92 3.00 2.11 3.00 2.00 0.587
Medication Efficacy (3p) 3.77 1.92 3.00 2.11 3.00 2.00 0.587
c- current; p- past; SUMD- scale to assess unawareness of mental disorder. 
The schizophrenia group had 13 patients who were never treated, 10 
regularly treated, and 13 irregularly treated. The insight between these 3 groups 
did not show any significant difference in the first 6 items of sumd both at 
admission and discharge. (ANOVA) 
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Table 21b.the association between Insight and prior treatment in mania at 
admission: 
NIL (n = 13) Regular  (n = 13) 
Irregular  
( n = 4) Unawareness of 
(SUMD Item) 
Mean S D Mean S D Mean S D 
p 
value 
Mental disorder (1c) 4.69 1.11 4.23 1.54 4.50 1.00 0.670 
Mental disorder (1p) 4.85 0.55 2.08 1.75 4.50 1.00 0.001 
Consequences (2c) 3.77 1.92 2.69 1.97 4.00 1.15 0.273 
Consequences (2p) 4.38 1.26 2.23 1.92 3.50 1.91 0.010 
Medication Efficacy (3c) 3.62 1.89 3.31 1.97 5.00 0.00 0.282 
Medication Efficacy (3p) 3.77 1.74 3.00 2.00 5.00 0.00 0.146 
c- current; p- past; SUMD- scale to assess unawareness of mental disorder. 
Among the mania patients, 13 had no prior treatment, 13 had regular 
treatment and 4 had irregular treatment.  
On using ANOVA (Analysis of Variance) and comparing the insight in 
these 3 groups, for the first 3 items of SUMD, it was found that, patients who 
had prior regular treatment had better awareness of mental disorder in the past 
(retrospective awareness), and better awareness of achieved effects of 
medication in past compared to those who had nil and irregular treatment. 
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DISCUSSION 
1. On comparing the sociodemographic variables it was found that both 
schizophrenia and mania patient groups were similar in most variable 
like age, sex and marital status except employment. 
2.  It was found that employment status was significantly better in mania 
(66.7%), compared to schizophrenia (16.7%). This is in line with the 
general view that the employment status of mania patients is better than 
schizophrenia patients. 
3. Prevalence of unawareness  
1.     It was found that 70% of schizophrenia patients and 83.3% of mania 
patients were unaware of their mental disorder at the time of admission 
(SUMD item 1c). The literature data of the prevalence of unawareness 
of illness ranges from 50% to80% in various studies. The prevalence of 
unawareness in our study also falls within this range. 
2. It was noted that although 70% of schizophrenia patients were unaware 
of mental disorder, only 40% were unaware of medication effects, and 
only 56% were unaware of social consequences. This means that a 
person may be unaware of mental disorder but still be aware of 
medication effects and social consequences. 
Similarly in mania, it was found that although 83% were unaware of 
mental disorder at the time of admission, only 53% were unaware of 
medication effects and 63% were aware of social consequences. 
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3.      It is also noted that although 70% of schizophrenia patients were unaware 
of current mental disorder at the time of admission, only 63% were 
unaware of past mental disorder. In other words, there are some patients 
who are unaware of current mental disorder but still aware of a past 
mental disorder. 
Similarly, although 83% of manic patients were unaware of mental 
disorder at present, only 60% were unaware of mental disorder in past. 
4. The mean insight score at admission was compared and no significant 
differences were noted between the 2 groups, namely, mania and 
schizophrenia in the first 6 items of SUMD. Our findings are consistent 
with findings of Amador et al., (1990) and Pini S, et al., (2001), who did 
not find any substantial difference in insight between schizophrenia and 
bipolar affective disorder. Our study does not lend support to evidence 
from other studies, which have shown schizophrenia to have a poorer 
insight compared to mania e.g., a study done by Pini, S in 2004 showed 
that schizophrenia subjects were much more compromised in insight 
dimensions than psychotic mania. Studies done by Fennig et al., (1996) 
also showed that lack of insight was more prevalent in schizophrenia. 
But our study has shown that in some of the aspects of insight related to   
awareness and attribution of symptoms, schizophrenia has a poorer 
insight as compared to mania for e.g., schizophrenia patients have a 
poorer retrospective awareness as well as retrospective attribution of 
hallucinations as compared to mania patients. Also schizophrenia 
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patients have a poorer attribution of poor social relationships to mental 
illness both in the current and past. 
5. Insight in schizophrenia and mania at admission versus discharge 
Comparison of insight scores at admission with insight scores at 
discharge showed that insight at discharge was significantly better compared to 
insight at admission both in schizophrenia and mania. In other words there was 
an improvement in insight during hospital stay and treatment.  
Studies suggest that approximately one-third of individuals with 
schizophrenia improve in awareness of their illness when they take 
antipsychotic medication. Studies also suggest that a larger percentage of 
individuals with bipolar disorder improve on medication.  
David, (1995), showed that 46% of the hospitalised psychotic patients 
showed improvement in insight during treatment. In our study also, patients 
had better insight at discharge as compared that at admission. 
Our findings are consistent with a meta- analysis done by Ghaemi et al., 
(2004), which showed that insight in mania showed 20% improvement after 
recovering from acute mania. In other words, insight improves in bipolar mood 
disorder with resolution of the acute manic episode. This suggests that insight 
in mania is state dependent. 
Our findings are also consistent with the studies done by Weiler et al., 
(2000), which showed that insight improves across diagnoses (schizophrenia, 
mania, depression). They too concluded that some aspects of insight are state 
related during exacerbation of illness in patients with schizophrenia and mania.  
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Our study lends evidence to support the theory that insight in psychotic 
illness like schizophrenia and mania is state dependent. 
6.    Correlation between insight and psychotic severity at admission in 
schizophrenia 
When correlation was analysed between unawareness at admission and 
total BPRS score, we found a significant negative correlation between 
unawareness and BPRS i.e., more the unawareness less severe the psychiatric 
symptoms. In other words patients with poor insight had less severe psychiatric 
symptoms and patients with better insight had higher psychiatric symptoms.  
This surprising finding is the exact opposite of some of the previous 
findings in studies done by Francis et al., 2001 & Williams et al., 2002 that 
found that better insight was associated with less severe psychiatric symptoms. 
This may be due to the fact that people with better insight had more 
severe anxiety, depression, somatisation and hypochondriacal symptoms and 
hence scored high on these items of BPRS in our study. 
7.  Correlation between insight and severity of psychotic symptoms at 
admission & discharge in mania 
In mania, both at admission and at discharge, we found a significant 
positive correlation between unawareness and psychotic severity i.e., more the 
unawareness, more the severity of psychotic symptoms. In other words patients 
with poor insight had more severe psychiatric symptoms and patients with 
better insight had less severe psychiatric symptoms.    
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This finding is consistent with previous studies done by Francis et al., 
(2001) and Williams et al., (2002), that patients with better insight had less 
severe psychiatric symptoms. 
8. Correlation between insight and severity of psychotic symptoms at      
discharge in schizophrenia 
No significant correlation was seen between unawareness and severity 
of psychotic symptoms in schizophrenia at the time of discharge.  
9.  Correlation between insight and global functioning at admission in 
schizophrenia  
When Correlation was analysed between global functioning and 
unawareness, we found a significant negative correlation between unawareness 
and global functioning i.e., more the unawareness, less the global functioning. 
In other words patients with poor insight had poor global functioning and 
patients with better insight had better global functioning. This is consistent with 
findings of Amador et al., (1994) and Pini S, et al., (2001). 
10. Correlation between insight and global functioning at discharge in 
schizophrenia 
No significant correlation between insight and global functioning was 
found at the time of discharge in schizophrenia patients. 
11. Correlation between insight and global functioning in mania  
No significant correlation was seen between unawareness and global 
functioning at admission in mania, both at admission as well as at discharge. 
 65
12. Insight and education 
In our study we were not able to find any association between insight 
and educational qualification (number of years of education). In other words, 
better educated people did not have a better insight as compared to the less 
educated. 
This is unlike the previous studies done by 
1) Cernovsky & Landmark (2004), which showed that people with poor 
insight had usually lower education 
2) MacPherson et al., (1996), also concluded that number of years spent in 
education explained proportion of insight 
3) Cernovsky in 1994 also showed that patients with high education were 
less frequently labeled as lacking insight. 
Our study does not give evidence for a similar conclusion 
13. Insight and number of episodes in mania 
It was found that patients with greater than 2 episodes had better insight, 
when compared with patients with less than 2 episodes, both during admission 
and discharge. It is interesting to note that studies done by Yen C F et al., 
(2004), also found that shorter duration of illness was associated with poorer 
insight. Our study also finds evidence for a similar conclusion. 
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14. Insight and duration of schizophrenia 
It was found schizophrenia patients with illness duration more than 2 
years did not have better insight from schizophrenia patients with illness of less 
than 2 years duration. 
15. Insight and prior treatment 
There was no difference in insight between the treated and untreated in 
the schizophrenia group, whereas in the mania group those with regular prior 
treatment had better retrospective insight compared to those who did not have 
regular prior treatment. 
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SUMMARY AND CONCLUSIONS 
A group of 30 patients with schizophrenia who were hospitalized were 
compared with 30 patients with mania who were hospitalized on 
sociodemographic profile and clinical variables. Validated scales were used to 
assess insight, psychotic severity and overall functioning at admission and 
discharge. It was found that insight in schizophrenia and mania did not have 
substantial differences. We found that insight improves during hospitalization 
and treatment in both the groups. We also conclude that some aspects of insight 
may be state dependent in both these groups. It was also observed that better 
insight is associated with lower psychotic symptoms in mania. But in 
schizophrenia, better insight was associated with higher psychotic severity at 
admission, probably because of higher scores on anxiety, somatization, 
hypochondriacal and depressive symptoms. We found that better the insight, 
better the psychosocial functioning in schizophrenia. We did not find any 
correlation between insight and global functioning in mania. We did not find 
any association between level of education and insight. We did not find any 
association between insight and duration of illness in schizophrenia. In mania, 
we found that patients with a greater number of episodes had better insight 
when compared with patients with less number of episodes. In schizophrenia 
patients, we found no association between prior treatment and insight. In mania 
patients, we found that patients with prior treatment had better retrospective 
insight as compared to those who had no treatment. 
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LIMITATIONS 
1. Smaller sample size 
2. The investigator did not receive any formal training in administering 
SUMD. He has applied it from the knowledge based on literature. 
3. Single investigator having done all the administration of scales. 
4. Sample has been collected from acute ward (family ward) of the institute 
and results may not be generalisable to outpatients and patients who are 
institutionalised. 
5. Study being of a naturalistic design did not control the treatment 
variables. 
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STRENGTHS 
1. Being of a naturalistic design, the study throws light on the real world 
evolution of symptoms like, psychotic severity, global functioning and 
insight. 
2. Most studies of insight have been done at a single point of time. This 
study has been done at two points of time i.e., at admission and 
discharge. 
 
FUTURE DIRECTIONS 
1. Comparison of insight in schizophrenia with other groups like 
depression and schizoaffective disorder. 
2. Correlation of lack of insight with neuropsychological deficits. 
3. More research is needed to determine the specific correlation between 
CBT, WCST and insight in schizophrenia. 
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SCALE TO ASSESS UNAWARENESS OF MENTAL DISORDER 
 1 awareness of mental disorder 0 1 2 3 4 5 
      Current(c) 
 Past (p) 
2. awareness of achieved effects of medication 0 1 2 3 4 5 
 C (Current) 
 P (Past) 
3. Awareness of social consequences of mental disorder 0 1 2 3 4 5 
C (Current) 
P (Past) 
4) Hallucination – 0 1 2 3 4 5 
Awareness 
C 
P 
Attribution 
C 
P     
5) Delusion 0 1 2 3 4 5 
Awareness 
C 
P 
Attribution 
C 
P 
6) Thought disorder 0 1 2 3 4 5 
Awareness 
C 
P 
Attribution 
C 
P 
7) Inappropriate affect 0 1 2 3 4 5 
Awareness 
C 
P 
Attribution 
C 
P 
8) Unusual appearance 0 1 2 3 4 5 
Awareness 
C 
P 
Attribution 
C 
P 
 
9) Stereotypic behavior 01 2 3 4 5 
Awareness 
C 
P 
Attribution 
C 
P 
10) Poor social judgment 0 1 2 3 4 5 
Awareness 
C 
P 
Attribution 
C 
P 
11) Poor control of aggressive impulses 0 1 2 3 4 5 
Awareness 
C 
P 
Attribution 
C 
P 
12) Poor control of sexual impulses 0 1 2 3 4 5 
Awareness 
C 
P 
Attribution 
C 
P 
13) Alogia 0 1 2 3 4 5 
Awareness 
C 
P 
Attribution 
C 
P 
14) Flat Affect 0 1 2 3 4 5 
Awareness 
C 
P 
Attribution 
C 
P 
 
15)Avolition- apathy 0 1 2 3 4 5 
Awareness 
C 
P 
Attribution 
C 
P 
16)Anhedonia/Asociality 0 1 2 3 4 5 
Awareness 
C 
P 
 
 
Attribution 
C 
P 
17) Poor attention 0 1 2 3 4 5 
Awareness 
C 
P 
Attribution 
C 
P 
18) Confusion-Disorientation 0 1 2 3 4 5 
Awareness 
C 
P 
Attribution 
C 
P 
19)Unusual eye contact 0 1 2 3 4 5 
Awareness 
C 
P 
Attribution 
C 
P 
 20)Poor social relationships 0 1 2 3 4 5 
Awareness 
C 
P 
Attribution 
C 
P 
 
Scoring: 0-Not applicable or symptom absent, 1-aware 
                3-somewhat aware, 5-unaware 
 
Sociodemographic and clinical profile 
 
Name:  
 
Age 
 
Sex 
 
O.P No.    I.P. No. 
 
marital status: unmarried/married/divorced/separated 
 
religion: Hindu,muslim,others. 
 
 Employment:Employed/Unemployed  
 
Occupation:laborer skilled/unskilled,clerical,professional/business 
 
 education-(high/low(primary(1-5),elementary(6-8) hig(9-10),higher 
sec(11,12),graduate,postgraduate 
 
 handedness(right/left) 
 
family: nuclear/ joint 
 
Socioeconomic class: less than 900. 900-3000,30000-9999,10000-20000,above 
20,000 
Diagnosis: 
Duration of illness: 
 
Continous/episodic: 
 
Episode number: 
 
Previous treatment:Regular/irregular 
 
Current treatment: 
GLOBAL ASSESSMENT OF FUNCTIONING (GAF) SCALE 
 
Consider psychological, social, and occupational functioning on a hypothetical 
continuum of mental health-illness. Do not include impairment in functioning due to 
physical (or environmental) limitations 
 
Code: (Note: Use intermediate codes when appropriate: eg. 45,68,72) 
100-91: Superior functioning in a wide range of activities, life's problems never seem 
to get out of hand, is sought out by others because of his or her many positive  
qualities. No symptoms. 
 
90-81: Absent or minimal symptoms (E.g., mild anxiety before an exam), good 
functioning in all areas, interested and involved in a wide range of activities, socially 
effective, generally satisfied with life, no more than everyday problems or concerns 
(e.g., an occasional argument with family members). 
 
80-71: If symptoms are present, they are transient and expectable reactions to 
psychosocial stressors (e.g., difficulty concentrating after family argument): no more 
than slight impairment in social, occupational, or school functioning (e.g. temporarily 
falling behind in schoolwork). 
 
70-61: Some mild symptoms (e.g., depressed mood and mild insomnia OR some 
difficulty in social, occupational, or school functioning (e.g., occasional truancy, or 
theft within the household), but generally functioning pretty well, has some 
meaningful interpersonal relationships. 
 
60-51 : Moderate symptoms (E.g., flat affect and circumstantial speech, occasional 
panic attacks) OR moderate difficulty in social, occupational, or school functioning 
(e.g., few friends, conflicts with peers or coworkers). 
 
50-41: Serious symptoms (e.g., suicidal ideation, severe obessional rituals, frequent 
shoplifting) OR any serious  impairment in social, occupational, or school functioning 
(e.g., no friends, unable to keep a job). 
 
40-31 : Some impairment in reality testing or communication (e.g., speech is at times 
illogical, obscure, or irrelevant) OR major impairment in several areas such as work 
or school, family relations, judgment, thinking, or mood (e.g., depressed man avoids 
friends, neglects family,  and is unable to work; child frequently beats up younger 
children, is defiant at home, and is failing at school. 
 
30-21 : Behavior is considerably influenced by delusions or hallucinations OR serious 
impairment in communication or judgment (e.g., sometimes incoherent, acts grossly 
inappropriately, suicidal preoccupation) OR inability to function in almost all areas. 
(e.g., stays in bed all day; no job, home, or friends). 
 
20-1: Some danger of hurting self or other (e.g, suicide attempts without clear 
expectation of death, frequently violent, manic excitement) OR occasionally fails to 
maintain minimal personal hygiene (e.g., smears feces) OR gross impairment in 
communication (e.g., largely incoherent or mute). 
 
10-1: Persistent danger of severely hurting self or others (e.g., recurrent violence) OR 
persistent inability to maintain minimal personal hygiene OR serious suicidal act with 
clear expectation of death. 
 
0: Inadequate information. 
